Android app Apple app link

Fate Therapeutics, Inc. (FATE) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$1.87

north_east
$0.07 (3.89%)
Day's range
$1.78
Day's range
$1.99

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
11/13/2024 BMO Capital Etzer Darout $5.00 $3.37   48.37%
08/14/2024 Stifel Nicolaus Benjamin Burnett $5.00 $3.27   52.91%
06/16/2024 Piper Sandler Edward Tenthoff $6.00 $3.61   66.44%
05/16/2024 H.C. Wainwright Debjit Chattopadhyay $5.00 $4.24   17.92%
05/10/2024 Piper Sandler Edward Tenthoff $4.00 $3.88   3.09%
05/10/2024 BMO Capital Etzer Darout $6.00 $3.87   55.24%
05/10/2024 Canaccord Genuity Bill Maughan $9.00 $3.90   130.77%
01/05/2023 Truist Financial Robyn Karnauskas $7.00 $11.00   -36.36%
12/14/2022 Goldman Sachs Andrea Tan $10.00 $15.37   -34.94%
12/12/2021 Oppenheimer Matthew Biegler $135.00 $48.98   175.62%
11/07/2021 Citigroup Yigal Nochomovitz $87.00 $60.79   43.12%
11/04/2021 Roth Capital Anthony Butler $60.00 $61.42   -2.31%
10/24/2021 Jefferies Michael Yee $145.00 $58.16   149.31%
08/19/2021 Piper Sandler Edward Tenthoff $113.00 $67.01   68.63%

Fate Therapeutics, Inc. FAQ's

Fate Therapeutics, Inc. has been rated by research analysts at Stifel Nicolaus, BMO Capital, Piper Sandler, H.C. Wainwright, Canaccord Genuity, Goldman Sachs in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.